Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Still Not Comfortable With New Vaccine Adjuvants, Industry Veterans Say

Sep 06 2010

• By The Pink Sheet

Related Content

FDA Lifts Clinical Hold On Dynavax's Hep B Vaccine Heplisav, Narrows Population

Sep 10 2009

Cervarix Gets One Up On Gardasil In Cross-Protection: HPV-31 In FDA Approval

Oct 16 2009

Wyeth Prevnar Vaccine: First Target Group Is 7 Mil. Infants Under Two

Feb 21 2000

Reformulated Vaccine Industry Grapples With Scientific, Regulatory, Reimbursement Challenges, But The Promise Is Great

Aug 18 2010

Vaccine Market Will Wax And Wane Next Year: Universal Flu Shot Recommendation Comes As Firms Lose Pandemic Sales

Mar 22 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window